Sign Up for a Free Account
  • Updated 08.24.2021
  • Released 12.16.1997
  • Expires For CME 08.24.2024

Gene therapy of glioblastoma



There is no satisfactory method for treating glioblastoma. Gene therapy is one of the promising innovative approaches. This article describes several methods of gene therapy applicable to brain tumors. Most of the initial clinical trials were with herpes simplex virus–thymidine kinase gene therapy, but it did not eliminate the tumor, which is a requirement for cure. Among the newer approaches, oncolysis by genetically modified bacteria appears to be the most promising approach.

Key points

• Several gene therapy approaches for brain tumors have been investigated in preclinical studies.

• Clinical trials have shown that gene therapy can be carried out safely but does not increase survival of the patients with glioblastoma.

• Some gene therapy strategies such as RNA interference may enhance the effect of concomitant chemotherapy.

• Innovative strategies for glioblastoma that are promising include targeted gene therapy delivered by nanoparticles.

Historical note and terminology

Historical aspects, nomenclature, and biology of glioblastoma are described in malignant astrocytomas. There was no remarkable development in the treatment of glioblastoma for nearly half a century, until the first clinical trial of the herpes simplex virus, thymidine kinase, and ganciclovir gene therapy system in glioblastoma (24). At the end of 1998, after completion of phase 3 clinical trials, this gene therapy approach was discontinued from further development because it failed to show efficacy. Various innovations employed to treat this condition are listed in Table 1 and some of these are linked to gene therapy. The number of current research projects to find a cure for glioblastoma exceeds 100, but thus far, none of these has succeeded in curing this disease. This article includes recent advances in gene therapy, as well as antisense therapy, considered to be a form of gene therapy.

Table 1. Innovative Therapies for Glioblastoma

New chemotherapeutic agents

Innovations for the delivery of anticancer drugs

• Intraoperative polymer implants in residual tumor bed containing anticancer drugs
• Magnetic cationic microsphere delivery system
• Chemotherapeutic agents incorporating biodegradable polymer wafers
• Stereotactic implantation of microspheres containing anticancer drugs
• Lipid-coated microbubbles as a delivery vehicle

Strategies to overcome the blood-tumor barrier for delivery of chemotherapy

• Intra-arterial chemotherapy
• Nanotechnology-based controlled delivery through blood-brain barrier

Chemotherapy sensitization

• Hyperbaric oxygen
• Photodynamic therapy for chemosensitization

Innovations of radiotherapy

• Boron neutron capture therapy
• Brachytherapy: implantation of interstitial radiation-emitting seeds into the tumor
• Enhancing effect of radiotherapy by hyperbaric oxygen
• Radiosurgery: enhancing effects of ionizing radiation

Inhibition of tumor growth

• Receptor tyrosine kinases as a signal blocker to hinder the growth of gliomas
• Telomerase inhibition
• Antiangiogenesis therapy
• Polyinosinic-polycytidylic acid given intramuscularly
• Thalidomide, systemic administration
• Targeting epidermal growth factor receptor-mediated metabolic pathway

Local destruction of tumor

• Genetical modified bacteria for tumor-specific lysis
• Hyperthermia
• Interleukin-4 fusion toxin injection
• Intraoperative photodynamic therapy
• Oncolysis by genetically modified viruses
• Tumor treating fields

Immune therapy

• Recombinant interleukin-2 and lymphokine activated killer cells
• Monoclonal antibodies
• Radiolabeled antibodies injected directly into the tumor
• Recombinant immunotoxins specific for epidermal growth factor receptor
• Biodegradable polymer implants containing immunotoxins
• Brain tumor vaccines

Cell therapy

• Encapsulated cells engineered to produce therapeutic molecules
• Grafting of stem cells producing therapeutic molecules, such as IL-4 gene

Gene therapy

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125